BioSpace News Archive

SOPHiA GENETICS today announced a collaboration with Exactis Innovation, based in Montreal, Quebec, who will contribute to cancer research and data-driven decision-making through SOPHiA GENETICS’ multimodal real-world data offering.

Zynex, Inc. announced it will participate virtually in the upcoming Needham Annual Growth Conference, which is being held January 16th-19th, 2024.

Atara Biotherapeutics, Inc. today announced that it has entered into a definitive agreement for the issuance and sale of pre-funded warrants to purchase 27,272,727 shares of its common stock at a purchase price of $0.55 per pre-funded warrant share in a registered direct offering to entities affiliated with an existing institutional investor.

Caresyntax today announced the launch of Caresyntax Clinical Data as a Service (CDaaS) for Medtech industry partners.

CoNextions Medical announced the CoNextions TR® Tendon Repair System has received an Innovative Technology contract from Vizient, Inc.

PTC Therapeutics, Inc. (NASDAQ: PTCT) will present an update on its commercial progress and R&D pipeline at the 42nd Annual J.P. Morgan Healthcare Conference today, Monday, January 8, at 10:30am EST/7:30am PST.

Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the nomination to its Board of Directors of Dr. Theresa Heah.

NeuroMetrix, Inc. (Nasdaq: NURO), announced today that it will present at the Emerging Growth Conference on January 10, 2024.

NanoImaging Services, the leading provider of cryo-electron microscopy services to the pharmaceutical and biotechnology communities, announced the appointment of John Rigg as Chief Executive Officer.

Progyny today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 8:15 A.M. Pacific Time / 11:15 A.M. Eastern Time.